Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Read original article on US Top News and Analysis →Related news
- Wall Street searches for direction after bank earnings and tech pressure
- Vision Capital Fund adds GOOGL and DDOG; exits TTD
- Speculative dollar positioning rebounds after midyear pullback
- ServiceNow could be the next software 'accelerator,' BNP Paribas says
- The Cass Index signals a minor freight rebound even as economic headwinds remain
- First Majestic says agrees in principle with Mexico on tax settlement framework
- 2027 has the ‘most negative flow picture’ for equities since 2002 – Paul Tudor Jones
-
Apple releases HomeView smart home hub with screen as showcase for Siri AI